New Zealand markets closed
  • NZX 50

    10,753.16
    -115.54 (-1.06%)
     
  • NZD/USD

    0.6168
    -0.0077 (-1.24%)
     
  • NZD/EUR

    0.5904
    -0.0049 (-0.83%)
     
  • ALL ORDS

    6,720.40
    -26.10 (-0.39%)
     
  • ASX 200

    6,539.90
    -28.20 (-0.43%)
     
  • OIL

    108.26
    +2.50 (+2.36%)
     
  • GOLD

    1,786.10
    -21.20 (-1.17%)
     
  • NASDAQ

    11,503.72
    -154.55 (-1.33%)
     
  • FTSE

    7,151.14
    -18.14 (-0.25%)
     
  • Dow Jones

    30,775.43
    -253.88 (-0.82%)
     
  • DAX

    12,771.68
    -12.09 (-0.09%)
     
  • Hang Seng

    21,859.79
    -137.10 (-0.62%)
     
  • NIKKEI 225

    25,935.62
    -457.42 (-1.73%)
     
  • NZD/JPY

    83.4280
    -1.2870 (-1.52%)
     

ZAP Surgical’s CEO and Stanford Neurosurgeon Receives Prestigious Janeway Medal, Recognized for Pioneering and Continued Advancement of Radiosurgical Brain Tumor Therapy

·4-min read

Dr. John R. Adler Awarded at American Radium Society Annual Meeting

SAN CARLOS, Calif., May 26, 2022--(BUSINESS WIRE)--ZAP Surgical Systems, Inc. today announced that Dr. John R. Adler, CEO of ZAP and Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University received the esteemed Janeway Medal at the annual American Radium Society (ARS) meeting in Scottsdale, Arizona. In addition to receiving the medal, Dr. Adler also delivered the Janeway Lecture entitled "Sometimes an Entrepreneur, Always a Doctor" to the meeting’s clinical delegation.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220525005269/en/

Dr. John R. Adler, CEO of ZAP Surgical and Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University receiving the Janeway Medal. June 21, 2022, Scottsdale, Arizona. (Photo: Business Wire)

Since 1933, ARS has sponsored the Janeway Lecture in memory of Dr. Henry Janeway (1873-1921), a celebrated American physician and pioneer of radiation medicine. Founded in 1916, ARS is the oldest society devoted to the study and treatment of cancer. ARS’s mission is to promote the multi-disciplinary and collegial study of all aspects of cancer.

As part of the Janeway Medal award, Dr. Adler was recognized for his early work in the radiosurgical treatment of spine tumors, acoustic neuromas, as well as trigeminal neuralgia. Dr. Adler was also recognized for his enterprising work in developing the surgical robots, including the CyberKnife® as well as ZAP-X® radiosurgery systems, that many neurosurgeons and radiation oncologists rely on today to treat cancer patients.

Dr. Adler graduated from Harvard College in 1976 and Harvard Medical School in 1980. From 1980 to 1987 he completed his neurosurgical residency at Massachusetts General Hospital and Brigham and Women's Hospital. Dr. Adler subsequently completed his radiosurgery fellowship at the Karolinska Institute in Sweden, where he worked directly with Professor Lars Leksell, the original pioneer of radiosurgery (SRS) and inventor of the Gamma Knife®. In 1987 Dr. Adler joined the faculty of Stanford University School of Medicine.

"The American Radium Society is honored to award the Janeway Medal to Dr. Adler,", said Dr. James Metz, ARS President and Chair of Radiation Oncology at the University of Pennsylvania. "Dr. Adler’s scientific contributions to the continued advancement of radiosurgery, including the invention of several key technology platforms, have had a profound impact on the way modern radiation medicine is delivered today."

"I’m incredibly flattered to be honored with this distinction," said Dr. John R. Adler. "Radiosurgery is perhaps one of the most important medical advancements in generations, and I’m very pleased that ARS works diligently in raising awareness and developing related collaboration across medical specialties."

Today the focus of Dr. Adler’s work is to reduce the barriers and costs of world-class radiosurgery and ultimately make this potentially life-saving procedure accessible to more patients in more locations. This passion has culminated in his latest invention, the ZAP-X® Gyroscopic Radiosurgery® platform. ZAP-X is recognized for being the first and only vault-free SRS delivery system, thereby eliminating the need for providers to build costly shielded radiation treatment rooms. Utilizing a modern linear accelerator to produce radiation, ZAP-X is also the first and only dedicated radiosurgery system to no longer require Cobalt-60 radioactive sources, consequently eliminating the significant efforts and costs to host, secure and regularly replace radioactive isotopes.

About ZAP Surgical Systems, Inc.

ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X® Gyroscopic Radiosurgery® platform. ZAP was founded in 2014 by Dr. John R. Adler. In addition to being CEO of ZAP, Dr. Adler is Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Dr. Adler is also renown as the inventor of the CyberKnife® system and founder of Accuray, Inc. The ZAP-X platform incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. ZAP-X also utilizes a modern linear accelerator to eliminate legacy use of Cobalt-60. Learn more at www.zapsurgical.com, or follow us on LinkedIn (https://www.linkedin.com/company/zapsurgical/) and Twitter (https://twitter.com/ZapSurgical).

View source version on businesswire.com: https://www.businesswire.com/news/home/20220525005269/en/

Contacts

Mark Arnold
Senior Vice President, Marketing
ZAP Surgical Systems, Inc.
Email: info@zapsurgical.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting